PubMed COVID-19 Clinical Care
3271 - 3280 of 3743 results found
Stevens-Johnson syndrome as a primary skin manifestation of COVID-19
Description
No abstract
Stratification of Pediatric COVID-19 cases by inflammatory biomarker profiling and machine learning
Description
An objective method to identify imminent or current Multi-Inflammatory Syndrome in Children (MIS-C) infected with SARS-CoV-2 is highly desirable. The aims was to define an algorithmically interpreted novel cytokine/chemokine assay panel providing
SARS-CoV-2 serological assay and viral testing: a report of professional football setting
Description
CONCLUSION: Our study revealed an inconsistency of results between the two tests; therefore, although application of serological assays alone seems insufficient in diagnosing COVID-19 disease, the findings are beneficial in the comprehension and the
Sex differences in cardiovascular complications and mortality in hospital patients with covid-19: registry based observational study
Description
CONCLUSIONS: In patients admitted to hospital for covid-19, female participants were less likely than male participants to have a cardiovascular complication. The differences between the sexes could not be attributed to the lower prevalence of pre
Sofosbuvir with daclatasvir and the outcomes of patients with COVID-19: a systematic review and meta-analysis with GRADE assessment
Description
CONCLUSION: SOF/DCV may reduce mortality rate and need for ICU/IMV in patients with COVID-19 while increasing the chance for clinical recovery.
Symposium 2 - COVID-19 diagnosis, therapy and outcome
Description
No abstract
Statin and mortality in COVID-19: a systematic review and meta-analysis of pooled adjusted effect estimates from propensity-matched cohorts
Description
CONCLUSION: In this meta-analysis of PSM-matched cohorts with adjusted analysis, statin was shown to decrease the risk of mortality in patients with COVID-19.
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice
Description
Several coronavirus (CoV) encoded proteins are being evaluated as targets for antiviral therapies for COVID-19. Included in this set of proteins is the conserved macrodomain, or Mac1, an ADP-ribosylhydrolase and ADP-ribose binding protein. Utilizing
